Equity Capital And Reserves Changement Date
Acadia Pharmaceuticals USD 431.76M 69.58M 2023-12
Agios Pharmaceuticals USD 811.02M 75.82M 2023-12
Amgen USD 6.23B 1.42B 2023-12
AstraZeneca USD 37.2B 195M 2023-09
Bayer EUR 33.38B 3.57B 2023-09
BioMarin Pharmaceutical USD 4.95B 54.65M 2023-12
Bluebird Bio USD 222.54M 66.48M 2023-09
Bristol-Myers Squibb USD 29B 2.98B 2023-09
Cytokinetics USD -386323000 52.48M 2023-12
Eisai JPY 861.67B 16.8B 2023-09
Eli Lilly USD 11.22B 156.6M 2023-09
Esperion Therapeutics USD -410004000 38.03M 2023-09
Exelixis USD 2.35B 180.32M 2023-09
Genmab DKK 31.11B 2.36B 2023-09
Incyte USD 5.19B 258.39M 2023-12
Ionis Pharmaceuticals USD 386.69M 71.23M 2023-12
Merck USD 41.25B 2.55B 2023-09
Moderna USD 13.85B 399M 2023-12
Nektar Therapeutics USD 159.37M 37.59M 2023-09
Neurocrine Biosciences USD 2B 149.1M 2023-09
Pfizer USD 96.93B 2.08B 2023-09
Takeda JPY 7.07T 149.3B 2023-09
Ultragenyx Pharmaceutical USD 275.41M 243.7M 2023-12
Xencor USD 668.8M 214K 2023-12



Exelixis Capitaux Propres Et Réserves - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Mar 2024.